FDA product code SCK: Ldt, Non-Molecular Antisera For Rare Rbc Antigens When There Is No Alternative Ivd

SCK is the FDA product code for ldt, non-molecular antisera for rare rbc antigens when there is no alternative ivd. It is a Not classified device, reviewed by the Hematology panel. Devices under SCK reach the market by 510(k) exempt; FDA lists no cleared 510(k)s for it.

Definition

Non-molecular antisera laboratory developed tests (LDTs) for rare red blood cell (RBC) antigens when manufactured and performed by blood establishments, including transfusion services and immunohematology laboratories, and when there is no alternative in vitro diagnostic product (IVD) available to meet the patient's need for a compatible blood transfusion within the scope described in Section V.B.3 of the preamble to the Final LDT Rule (89 FR 37286).

Classification

FieldValue
Device nameLdt, Non-Molecular Antisera For Rare Rbc Antigens When There Is No Alternative Ivd
Device classNot classified
Review panelHE — Hematology
Medical specialtyUnknown
Premarket route510(k) exempt

Recalls for SCK devices

FDA recall records list no recalls for product code SCK.

Frequently asked questions

What is FDA product code SCK?

SCK is the FDA product code for ldt, non-molecular antisera for rare rbc antigens when there is no alternative ivd. It is a Not classified device, reviewed by the Hematology panel.

What device class is SCK?

Not classified. Typical premarket route: 510(k) exempt.

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Hematology product codes · FDA product code lookup · 510(k) database search · 510(k) review times